Yayoi Kawata
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Real-World Vortioxetine Prescription for Patients With Major Depressive Disorder in Japan: A Retrospective Cohort Study Using a Japanese Health Insurance Claims Database.
Journal: Neuropsychopharmacology reports
Published: December 03, 2025
Gender differences in prescribing patterns for patients with Parkinson's disease in Japan: a retrospective observational study using insurance claims databases.
Journal: Frontiers in neurology
Published: February 05, 2025
Multi-layer platform coordination for open innovation in oligonucleotide therapeutics.
Journal: Drug discovery today
Published: October 20, 2024
Open Innovation and Regulatory Challenges in New Modality Development: The Pivotal Role of Contract Development and Manufacturing Organisations in Advancing Antibody Drugs.
Journal: Therapeutic innovation & regulatory science
Published: March 23, 2024
Prescribing patterns and determinants for elderly patients with Parkinson's disease in Japan: a retrospective observational study using insurance claims databases.
Journal: Frontiers in neurology
Published: February 09, 2023
Survey on the Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease and Their Caregivers in Japan.
Journal: Patient preference and adherence
Published: December 21, 2022
Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage display.
Journal: Biochemical and biophysical research communications
Published: September 27, 2016
A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models.
Journal: European journal of pharmacology
Published: July 05, 2016
Correction to Melanin-Concentrating Hormone Receptor 1 Antagonists Lacking an Aliphatic Amine: Synthesis and Structure-Activity Relationships of Novel 1-(Imidazo[1,2-a]pyridin-6-yl)pyridin-2(1H)-one Derivatives.
Journal: Journal of medicinal chemistry
Published: April 06, 2016
Amine-free melanin-concentrating hormone receptor 1 antagonists: Novel non-basic 1-(2H-indazole-5-yl)pyridin-2(1H)-one derivatives and mitigation of mutagenicity in Ames test.
Journal: Bioorganic & medicinal chemistry
Published: March 01, 2016
Amine-free melanin-concentrating hormone receptor 1 antagonists: Novel 1-(1H-benzimidazol-6-yl)pyridin-2(1H)-one derivatives and design to avoid CYP3A4 time-dependent inhibition.
Journal: Bioorganic & medicinal chemistry
Published: February 23, 2016
Last Updated: 09/26/2026